N/A N=180 Randomized Treatment

Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA

Preprocedure Anxiety

Bottom Line

View on ClinicalTrials.gov: NCT03662607 ↗

Enrolled (actual)

180

Serious AEs

0.0%

Results posted

Mar 2025

Primary outcome: Primary: Change in Anxiety Measured by the Sate-Trait Anxiety Inventory (STAI) — 69.81; 65.71 Mean STAI score

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Virtual reality experience (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Corewell Health West
Primary completion: Nov 2021

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Anxiety Measured by the Sate-Trait Anxiety Inventory (STAI)	69.81; 65.71	—

Summary

The primary aim of this study is to test the hypothesis that use of VR combined with standard procedural education will result in less pre-procedural anxiety than standard procedural education alone among patients undergoing first-time cardiac catheterization. The VR technology being evaluated in this study will allow patients to experience a 3-D simulation of certain aspects of their upcoming procedure prior to the actual procedure date.

Eligibility Criteria

Inclusion Criteria

Scheduled to undergo a left-heart catheterization procedure at the Meijer Heart Center
18-75 years of age
Signed study consent form

Exclusion Criteria

History of cardiac procedure(s) in a cardiac catheterization laboratory
History of seizures, migraine headaches or severe susceptibility to motion sickness
Currently taking psychotropic drugs or on long-term psychotropic treatment
Unable to read and speak English
Visually impaired
Unable to provide written consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03662607). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.